OncLive - Bringing the Oncology Community Together

Education ▼

Conference Coverage

NewsNetwork

OncLive TV

PEER EXCHANGE

OncLive INSIGHTS

LIVE BROADCAST 5/11 2 PM EDT - Androgen Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Latest News

Advances Continue With Targeted Agents in ALK+ NSCLC

Paul K. Paik, MD, discusses treatment advances and sequencing strategies for patients with ALK-positive NSCLC. Read More >>

Landgren Explains Evolving Myeloma Landscape

Expert Shares Insight on Navigating Neuroendocrine Tumor Treatment

Expert Discusses Frontline Osimertinib Approval and Next Steps in EGFR+ NSCLC

Expert Highlights Evolving Role of BMT in Hematologic Malignancies

Therapeutic Options Continue to Grow for HCC

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Duffield on Implications for Immunotherapy in Nasopharyngeal Carcinoma

CDK 4/6 Inhibitors in Mantle Cell Lymphoma

Dr. Kopetz Discusses the Treatment of BRAF-Mutant CRC

Dr. Monk on Combination Therapies in Patients With Ovarian Cancer

Dr. Nathwani on the Standard of Care in Patients With Newly Diagnosed Multiple Myeloma

Dr. Wolf on the Treatment of High-Risk Patients With Multiple Myeloma

Dr. Ginsburg Addresses Global Disparities in Cervical Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Immunotherapy Options in Refractory CRC$

Immunotherapy Options in Refractory CRC

Guidelines for Early Detection of Metastasis in CRPC

Metastatic Renal Cell Carcinoma: When to Switch Therapy

Treatment Challenges in Nonmetastatic CRPC

Take-Home Messages on Breast Oncology Advances

OncLive houses thousands of videos that provide updates and information.
See more Videos

Immunotherapy in Metastatic NSCLC

Patient Selection for Frontline Bevacizumab in NSCLC

Rationale Behind Antiangiogenic Therapy in NSCLC

Radiotherapy Strategies in Locally Advanced NSCLC

Impact of Prognostic Factors on Clinical Decisions in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More